NATIONAL NOSOCOMIAL INFECTIONS SURVEILLANCE SYSTEM H. SECULAR TREND OF HOSPITAL-ACQUIRED CANDIDEMIA AMONG INTENSIVE CARE UNIT PATIENTS IN THE UNITED STATES DURING 1989-1999

By W. Trick, S. Fridkin. 2002

672 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Guidelines for treatment of candidiasis. (2004, background): “Although Candida albicans remains the most common pathogen in oropharyngeal and cutaneous candidiasis, non-albicans species of Candida are increasingly associated with invasive candidiasis [1–5].”
Incidence of Bloodstream Infections Due to Candida Species and In Vitro Susceptibilities of Isolates Collected from 1998 to 2000 in a Population-Based Active Surveillance Program (2004, background): “Died within 30 days of culturing 205 (40) 204 (33) 100 (36) 57 (40) 28 (18) 409 (36)”
Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. (2012, unknown): “Moreover, longitudinal studies have detected a global shift in epidemiology toward non-albicans Candida species, particularly Candida glabrata [14–22].”
Epidemiology of Invasive Mycoses in North America (2010, background): “Indeed, among persons without AIDS the incidence of cryptococcosis in the U.S. has been shown to be 0.2 to 0.8 per 100,000 population per year and has remained unchanged for more than a decade (Hajjeh et al. 1999; Mirza et al. 2003).”